The American Journal of Managed Care

Assessing the Impact of Transplant Case Management on Clinical Outcomes

Objectives: Case management is commonly used by health plans to attempt to improve the care received by their members who have complex needs, such as those who undergo transplantation. There are few ...
Kaleido Scope

Clinical Research Management (CRM)

The Clinical Research Management (CRM) specialty track provides the education and training needed to manage clinical trials research, including knowledge needed to ensure that clinical trials adhere ...

Curiex Announces Formal Launch as a Next-Generation Site Management Organization for Clinical Trials

RENTON, WA, UNITED STATES, January 13, 2026 / EINPresswire.com / — Curiex today announced its formal launch as a next-generation Site Management Organization (SMO), redefining how clinical trials are ...
Business Wire

Allay Therapeutics’ Phase 2B Clinical Study Supports Ability of ATX101 To Deliver Four Weeks of Sustained Post-surgical Pain Relief

SAN JOSE, Calif.--(BUSINESS WIRE)--Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation, ...
WHNT

BIOVAXYS ACQUIRES CLINICAL STUDY MANAGEMENT COMPANY AND COMPLETES PRIVATE PLACEMENT

VANCOUVER, BC, March 16, 2023 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") today announced that it has ...
The American Journal of Managed Care

Suboptimal Cardiovascular Risk Management Found in Mexican Adults With Diabetes

Cardiovascular risk factor control in Mexican adults with diabetes is suboptimal, with low rates of glycemic, blood pressure, ...
Business Insider

Tharimmune Announces Phase 2 Study Plan for TH104 in Patients With Moderate-to-Severe Pruritus Associated With Primary Biliary Cholangitis and Provides a Business Update

Tharimmune, Inc. (Nasdaq:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company committed to pioneering therapies in immunology and inflammation, today announced plans for ...
Business Insider

Kalytera Announces Initiation of Phase 2 Clinical Study in Prevention of Graft Versus Host Disease and Agreement with The Salzman Group of Israel to Manage and Partially Fund ...

SAN FRANCISCO and TEL AVIV, Israel, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX-V:KALY) and (OTCQB:KALTF) (the "Company" or "Kalytera") today announced the initiation of a Phase ...

Almirall announces “LumiNE”, a Phase III clinical study assessing the efficacy of lebrikizumab for the treatment of nummular eczema

Nummular eczema is a debilitating skin condition that is distinct from atopic dermatitis but involves similar disease mechanisms including IL-13 and therefore makes targeting IL-13 with lebrikizumab a ...